Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder (NCT06229210)
An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder
🩺 Plain-English Summary (8th-Grade Level)
This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder.
Who can join: Review the eligibility criteria below.
Location: Southwest Autism Research and Resource Center — Phoenix, Arizona
Age range: 5 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (64 Sites)
Showing the first 25 of 64 sites.
- Southwest Autism Research and Resource Center — Phoenix, Arizona
- Pillar Clinical Research, LLC — Little Rock, Arkansas
- Advanced Research Center, Inc — Anaheim, California
- National Institute Of Clinical Research — Garden Grove, California
- Excell Research Inc — Oceanside, California
- Inland Psychiatric Medical Group Inc — Redlands, California
- University Of California - Davis — Sacramento, California
- University Of California San Diego — San Diego, California
- Next Level Clinical Trials, LLC — West Covina, California
- MCB Clinical Research Centers LLC — Colorado Springs, Colorado
- Royal Palm Clinical Research — Fort Myers, Florida
- Sarkis Clinical Trials — Gainesville, Florida
- United Research Institute — Hialeah, Florida
- Advanced Research Institute of Miami — Homestead, Florida
- Green Leaf Clinical Trials — Jacksonville, Florida
- Vital Care Research — Miami, Florida
- Columbus Clinical Services LLC — Miami, Florida
- Care Research Center Inc — Miami, Florida
- Blue Medical Research — Miami, Florida
- AP Medical Research — Miami, Florida
- Envision Trials LLC — Miami, Florida
- GTL Medical and Research Group — Miami, Florida
- Diverse Clinical Research LLC — Miami, Florida
- Links Clinical Trials — Miami, Florida
- New Med Research Inc — Miami Gardens, Florida
📞 Contact the Study Coordinator
Phone: (844) 434-4210
Email: Participate-In-This-Study1@its.jnj.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia
- Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
- Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
- Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
- Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
- Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
- Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia
Explore by condition: All Schizophrenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.